February 14, 2022
Now available KIMMTRAK® (tebentafusp-tebn)
KIMMTRAK® (tebentafusp-tebn) is a bispecific gp100 peptide-HLA-directed CD3 T cell engager indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
Please see the full prescribing information.